| Authors: |
Chen H; Centre for Biomedical Data Science (CBDS), Duke-NUS Medical School, Singapore, Republic of Singapore, 169857.; Duke-NUS AI + Medical Sciences Initiative (DAISI), Duke-NUS Medical School, Singapore, Republic of Singapore, 169857.; Cardiovascular and Metabolic Disorders (CVMD) Programme, Duke-NUS Medical School, Singapore, Republic of Singapore, 169857., Seow SW; Precision Health Research, Singapore (PRECISE), Singapore., Coffman T; Cardiovascular and Metabolic Disorders (CVMD) Programme, Duke-NUS Medical School, Singapore, Republic of Singapore, 169857., Tan P; Precision Health Research, Singapore (PRECISE), Singapore.; Genome Institute of Singapore, Agency for Science, Technology and Research, Singapore.; Cancer and Stem Cell Biology (CSCB) Programme, Duke-NUS Medical School, Singapore, Republic of Singapore, 169857., Petretto E; Centre for Biomedical Data Science (CBDS), Duke-NUS Medical School, Singapore, Republic of Singapore, 169857.; Duke-NUS AI + Medical Sciences Initiative (DAISI), Duke-NUS Medical School, Singapore, Republic of Singapore, 169857.; Cardiovascular and Metabolic Disorders (CVMD) Programme, Duke-NUS Medical School, Singapore, Republic of Singapore, 169857.; Institute for Big Data and Artificial Intelligence in Medicine, School of Science, China Pharmaceutical University (CPU), Nanjing, Jiangsu, China, 211198. |